Time Trends in Antipsychotic Drug Use in Patients with Dementia: A Nationwide Study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Time Trends in Antipsychotic Drug Use in Patients with Dementia : A Nationwide Study. / Nørgaard, Ane; Jensen-Dahm, Christina; Gasse, Christiane; Hansen, Hanne Vibe; Waldemar, Gunhild.

I: Journal of Alzheimer's Disease, Bind 49, Nr. 1, 2016, s. 211-20.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Nørgaard, A, Jensen-Dahm, C, Gasse, C, Hansen, HV & Waldemar, G 2016, 'Time Trends in Antipsychotic Drug Use in Patients with Dementia: A Nationwide Study', Journal of Alzheimer's Disease, bind 49, nr. 1, s. 211-20. https://doi.org/10.3233/JAD-150481

APA

Nørgaard, A., Jensen-Dahm, C., Gasse, C., Hansen, H. V., & Waldemar, G. (2016). Time Trends in Antipsychotic Drug Use in Patients with Dementia: A Nationwide Study. Journal of Alzheimer's Disease, 49(1), 211-20. https://doi.org/10.3233/JAD-150481

Vancouver

Nørgaard A, Jensen-Dahm C, Gasse C, Hansen HV, Waldemar G. Time Trends in Antipsychotic Drug Use in Patients with Dementia: A Nationwide Study. Journal of Alzheimer's Disease. 2016;49(1):211-20. https://doi.org/10.3233/JAD-150481

Author

Nørgaard, Ane ; Jensen-Dahm, Christina ; Gasse, Christiane ; Hansen, Hanne Vibe ; Waldemar, Gunhild. / Time Trends in Antipsychotic Drug Use in Patients with Dementia : A Nationwide Study. I: Journal of Alzheimer's Disease. 2016 ; Bind 49, Nr. 1. s. 211-20.

Bibtex

@article{a55689e2d80642e78ee3c0f8c83bb40c,
title = "Time Trends in Antipsychotic Drug Use in Patients with Dementia: A Nationwide Study",
abstract = "BACKGROUND: Antipsychotics are often used to treat neuropsychiatric symptoms in dementia, but the evidence for effect is limited. Antipsychotics have been associated with increased risk of adverse events and mortality in patients with dementia, leading to safety regulations worldwide.OBJECTIVE: To investigate time trends in use of antipsychotics and other psychotropic drugs in dementia care.METHODS: The study included longitudinal data on all Danish residents ≥65 years. The study population was defined on January 1 of each year from 2000-2012. Data included prescriptions, discharge diagnoses, and somatic and psychiatric comorbidities. Multivariate time trend analyses of psychotropic drug use in patients with dementia within 4-year age bands were performed.RESULTS: Overall, among patients with dementia the prevalence of antipsychotic drug use decreased from 31.3% in 2000 to 20.4% in 2012. The decreasing use of antipsychotics was accompanied by decreasing use of anxiolytics and hypnotics/sedatives, but an increase in the use of antidepressants from 43.3% in 2000 to 53.8% in 2012. These changes were significant across almost all age groups. Treatment intensity among patients using antipsychotics increased as the annual median number of defined daily doses (DDD) increased from 33.3 to 42.0 DDD.CONCLUSIONS: The changing patterns of psychotropic drug use may be caused by warnings against use of antipsychotics. Further research is needed to explore the implications for patient safety.",
author = "Ane N{\o}rgaard and Christina Jensen-Dahm and Christiane Gasse and Hansen, {Hanne Vibe} and Gunhild Waldemar",
year = "2016",
doi = "10.3233/JAD-150481",
language = "English",
volume = "49",
pages = "211--20",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "I O S Press",
number = "1",

}

RIS

TY - JOUR

T1 - Time Trends in Antipsychotic Drug Use in Patients with Dementia

T2 - A Nationwide Study

AU - Nørgaard, Ane

AU - Jensen-Dahm, Christina

AU - Gasse, Christiane

AU - Hansen, Hanne Vibe

AU - Waldemar, Gunhild

PY - 2016

Y1 - 2016

N2 - BACKGROUND: Antipsychotics are often used to treat neuropsychiatric symptoms in dementia, but the evidence for effect is limited. Antipsychotics have been associated with increased risk of adverse events and mortality in patients with dementia, leading to safety regulations worldwide.OBJECTIVE: To investigate time trends in use of antipsychotics and other psychotropic drugs in dementia care.METHODS: The study included longitudinal data on all Danish residents ≥65 years. The study population was defined on January 1 of each year from 2000-2012. Data included prescriptions, discharge diagnoses, and somatic and psychiatric comorbidities. Multivariate time trend analyses of psychotropic drug use in patients with dementia within 4-year age bands were performed.RESULTS: Overall, among patients with dementia the prevalence of antipsychotic drug use decreased from 31.3% in 2000 to 20.4% in 2012. The decreasing use of antipsychotics was accompanied by decreasing use of anxiolytics and hypnotics/sedatives, but an increase in the use of antidepressants from 43.3% in 2000 to 53.8% in 2012. These changes were significant across almost all age groups. Treatment intensity among patients using antipsychotics increased as the annual median number of defined daily doses (DDD) increased from 33.3 to 42.0 DDD.CONCLUSIONS: The changing patterns of psychotropic drug use may be caused by warnings against use of antipsychotics. Further research is needed to explore the implications for patient safety.

AB - BACKGROUND: Antipsychotics are often used to treat neuropsychiatric symptoms in dementia, but the evidence for effect is limited. Antipsychotics have been associated with increased risk of adverse events and mortality in patients with dementia, leading to safety regulations worldwide.OBJECTIVE: To investigate time trends in use of antipsychotics and other psychotropic drugs in dementia care.METHODS: The study included longitudinal data on all Danish residents ≥65 years. The study population was defined on January 1 of each year from 2000-2012. Data included prescriptions, discharge diagnoses, and somatic and psychiatric comorbidities. Multivariate time trend analyses of psychotropic drug use in patients with dementia within 4-year age bands were performed.RESULTS: Overall, among patients with dementia the prevalence of antipsychotic drug use decreased from 31.3% in 2000 to 20.4% in 2012. The decreasing use of antipsychotics was accompanied by decreasing use of anxiolytics and hypnotics/sedatives, but an increase in the use of antidepressants from 43.3% in 2000 to 53.8% in 2012. These changes were significant across almost all age groups. Treatment intensity among patients using antipsychotics increased as the annual median number of defined daily doses (DDD) increased from 33.3 to 42.0 DDD.CONCLUSIONS: The changing patterns of psychotropic drug use may be caused by warnings against use of antipsychotics. Further research is needed to explore the implications for patient safety.

U2 - 10.3233/JAD-150481

DO - 10.3233/JAD-150481

M3 - Journal article

C2 - 26444790

VL - 49

SP - 211

EP - 220

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 1

ER -

ID: 162851522